Skip to main content

Table 3 Clinical features of 17 patients with dual primary breast and lung cancer with pathogenic or likely pathogenic variants

From: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer

Patient IDa

Gene

Variant

Consequence

Family History (Age at Dx)

Breast cancer

Lung cancer

Temporal occurrence of Br and Lung Ca Dx

Age at Dx (years)

Histo type (Laterality)

ER/PR/Her2 status

Age at Dx (years)

Histo type

Smoking history

EGFR status

H3168

FANCA

rs2039260856 (T)

Stop gain

Sis Lung Ca (> 50); Sis Br Ca (58); Fa HNSCC (62)

45

ILC (L)

Unk

66

ADC

None

E746_A75del

Br before Lung Ca

 

PALB2

rs878855123 (A)

Stop gain

         

H1641

BRCA2

rs1555283001 (G)

Stop gain

Mo Pancreatic Ca (70 +)

56

IDC (L)

ER + /PR-/Her2 + 

64

ADC

None

E746_A75del

Br before Lung Ca

H1362

BRIP1

rs775537066 (CA)

Stop gain

No known

60

IDC (L)

ER-/PR-/Her2 + 

63

LELC

None

Unk

Br before Lung Ca

H1409

RAD51D

rs753862052 (TTA)

Frameshift ins

Mo Col Ca (Unk); Sis Ov Ca (Unk)

68

IDC (R)

ER + /PR-/Her2-

68

ADC

None

WT

Synchronous

H2590

TP53

rs587782144 (T)

Nonsyn. SNV

No known

49

NOS (R), IDC (L)

Unk (R), ER + /PR-/Her2- (L)

74

ADC

None

E746_A75del

Br before Lung Ca

H3587

EXT2

chr11:g.44109284G > C

Splice site

Bro Pros Ca (Unk)

53

IDC (R)

ER + /PR + /Her2-

60

LCNEC

None

Unk

Br before Lung Ca

H1026

BRIP1

rs1426528935 (T)

Frameshift del

Fa Lung Ca (Unk); Mo Lung Ca (Unk); Sis Br Ca (Unk)

46

NOS (L)

Unk

55

ADC

None

E746_A75del

Br before Lung Ca

H3539

FANCA

rs755104393 (G)

Splice site

Niece Lung Ca (40 +)

63

IDC (R)

ER + /PR + /Her2-

75

ADC

None

N771_P772insPH

Br before Lung Ca

H4324

WWOX

rs758588684 (C)

Start loss

No known

47

IDC (R)

Unk

63

ADC

None

WT

Br before Lung Ca

H2552

GATA2

rs1166272013 (G)

Splice site

No known

59

DCIS (R)

ER + /PR-/Her Unk

59

ADC

None

WT

Synchronous

H3400

ERCC6/PGBD3

rs181055741 (A)

Stop gain

Bro Pros Ca (63); Fa HNSCC (70)

62

MADC (L)

ER + /PR + /Her2 + 

62

ADC

None

E746_A75del

Synchronous

H4270

TP53

rs1019340046 (G)

Nonsyn. SNV

Fa Gastric Ca (40)

34

DCIS (R), IDC (L)

Unk (R), ER + /PR + /Her2 Unk (L)

52

SCLC

None

WT

Br before Lung Ca

H1758

GPC3

rs1158430569 (T)

Nonsyn. SNV

No known

68

IDC (R)

ER + /PR + /Her2 Equiv

69

ADC

None

L858R

Br before Lung Ca

H4326

MSH2

rs768572053 (G)

Nonsyn. SNV

Sis Lung Ca (60); Sis Lung Ca (69)

64

DCIS (R)

ER + /PR + /Her2 Unk

59

ADC

Former

WT

Lung before Br Ca

 

PTEN

chr10:g.87864072TCTA > T

Non-frameshift del

         

H3053

WRN

rs569405870 (A)

Nonsyn. SNV

No known

65

IDC (R)

ER + /PR + /Her2-

65

ADC

None

WT

Synchronous

H2235

FANCI

rs747603151 (T)

Non-frameshift del

Sis Ute Ca (40 +); Fa Unk (60–70)

67

IDC (R), ILC (R)

ER + /PR + /Her2-

74

ADC

None

WT

Br before Lung Ca

H2420

KMT2A

chr11:g.118436698C > CGCG

Non-frameshift ins

No known

63

IDC (L)

ER + /PR + /Her2-

72

ADC

None

Exon19del

Br before Lung Ca

  1. ADC, adenocarcinoma; Br, breast; Bro, brother; C, Chinese; Ca, cancer; Col, colorectal; DCIS, ductal carcinoma in-situ; Del., deletion; Dx, diagnosis; EGFR, epidermal growth factor receptor; Equiv, equivocal; ER, oestrogen receptor; Fa, father; Histo, histological; HNSCC, head and neck squamous cell carcinoma; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; Ins., insertion;L, left; LCNEC, large cell neuroendocrine lung carcinoma; LELC, lymphoepithelioma-like carcinoma; Li, liver; MADC, mucinous adenocarcinoma; Mo, mother; Nonsyn., non-synonymous; NOS, not otherwise specified; NPC, nasopharyngeal cancer; NSCLC, non-small cell lung cancer; Ov, ovarian; PR, progesterone receptor; Pros, prostate; R, right; SCLC, small cell lung cancer; Sis, sister; SNV, single nucleotide variant; Unk, unknown; Ute, uterine; WT, wildtype
  2. aPatients in the breast and lung cohort with variants, all of whom are heterozygous for their corresponding variants